Share class: Bio-Techne Corporation

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A1158,891,800157,235,821 ( 98.96 %) 0 98.96 %

Major shareholders: Bio-Techne Corporation

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
11.53 %
18,318,964 11.53 % 1 320 M $
BlackRock Advisors LLC
7.004 %
11,129,401 7.004 % 802 M $
T. Rowe Price International Ltd.
5.931 %
9,424,313 5.931 % 679 M $
State Street Corp.
4.025 %
6,395,993 4.025 % 461 M $
Eaton Vance Management
2.931 %
4,657,591 2.931 % 335 M $
BAMCO, Inc.
2.798 %
4,445,540 2.798 % 320 M $
Columbia Wanger Asset Management LLC
2.76 %
4,385,593 2.76 % 316 M $
Geode Capital Management LLC
2.456 %
3,902,636 2.456 % 281 M $
LB Hercules Holdings LLC
2.213 %
3,516,092 2.213 % 253 M $
Invesco Advisers, Inc.
2.179 %
3,461,708 2.179 % 249 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional81.13%
Other10.61%
State Street Corp.4.03%
Sumitomo Mitsui Trust Group, Inc.1.28%
Individuals1.04%
SEI Investments Co.0.34%
Schweizerische Nationalbank0.29%
Manulife Financial Corp.0.13%
Governments0.11%
Skandinaviska Enskilda Banken AB0.02%
Zions Bancorporation NA0.02%
Corebridge Financial, Inc.0.02%
ING Groep NV0.01%
The Bank of Nova Scotia0.01%
Banco Bilbao Vizcaya Argentaria SA0.01%
Rathbones Group Plc0.01%
Fifth Third Bancorp0.01%
Unknown0.93%

Based on 1000 largest holdings

Geographical origin of shareholders

United States 75.74%
United Kingdom 11.97%
Canada 4.19%
Japan 1.74%
Norway 1.25%
Individuals 1.04%
Netherlands 0.62%
Australia 0.57%
Switzerland 0.49%
Sweden 0.28%
Luxembourg 0.26%
United Arab Emirates 0.16%
Denmark 0.13%
Germany 0.12%
Ireland 0.12%
France 0.11%
Finland 0.05%
Spain 0.05%
South Korea 0.04%
Singapore 0.03%
Czech Republic 0.02%
Italy 0.02%
Hong Kong 0.01%
China 0.01%
South Africa 0.01%
Austria 0.01%
Malaysia 0.01%
Belgium 0.01%
Poland 0.01%

Based on 1000 largest holdings

Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools 71.5%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.1%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.4%). Net sales are distributed geographically as follows: the United States (56.7%), the United Kingdom (4.3%), Europe-Middle East-Africa (20.8%), China (8.6%), Asia-Pacific (6.5%) and others (3.1%).
Employees
3,100
More about the company